scholarly journals Hypoxia-mediated tumour targeting

Gene Therapy ◽  
2003 ◽  
Vol 10 (7) ◽  
pp. 540-549 ◽  
Author(s):  
K Binley ◽  
Z Askham ◽  
L Martin ◽  
H Spearman ◽  
D Day ◽  
...  
Keyword(s):  
Author(s):  
S Martel

In the field of medical nanorobotics, nanometre-scale components and phenomena are exploited within the context of robotics to provide new medical diagnostic and interventional procedures, or at least to enhance the existing ones. The best route for such miniature robots to access various regions inside the human body is certainly the vascular network. Such a network is made of nearly 100 000 km of blood vessels varying in diameters from a few millimetres in the arteries down to ∼ 4 μm in the capillaries with respective important variations in blood flow velocities. When injected in the blood circulatory network using existing modern techniques such as catheterization, such robots must travel from larger-diameter vessels before reaching much tinier capillaries. As such, the use of a single type of microscale robots capable of travelling in various environments and conditions related to such different blood vessels while being trackable by an external system seems, at the present time, inconceivable. Therefore, as explained in this article, an approach based on the use of several types of microscale robots with complementary methods of propulsion and steering capable of operating in a collective manner is more likely to achieve better results. This is especially true for interventions such as direct tumour targeting where the tiniest blood vessels such as the ones found in the angiogenesis network must be travelled.


2000 ◽  
Vol 43 (2-3) ◽  
pp. 165-196 ◽  
Author(s):  
Fredrik Nilsson ◽  
Lorenzo Tarli ◽  
Francesca Viti ◽  
Dario Neri

2012 ◽  
Vol 393 ◽  
pp. 328-333 ◽  
Author(s):  
Amelia J. Wagstaff ◽  
Sarah D. Brown ◽  
Megan R. Holden ◽  
Gemma E. Craig ◽  
Jane A. Plumb ◽  
...  

2007 ◽  
Vol 15 (7-8) ◽  
pp. 546-551 ◽  
Author(s):  
Kerry D. Fisher ◽  
Nicola K. Green ◽  
Ashley Hale ◽  
Vladimir Subr ◽  
Karel Ulbrich ◽  
...  

Nanoscale ◽  
2018 ◽  
Vol 10 (15) ◽  
pp. 6812-6819 ◽  
Author(s):  
Wei Jiang Goh ◽  
Shui Zou ◽  
Bertrand Czarny ◽  
Giorgia Pastorin

A hybrid drug delivery platform involving the fusion of cell membranes from U937 monocytes and synthetic lipids to create nano–cell vesicle technology systems (nCVTs) is designed.


2001 ◽  
pp. 498-512
Author(s):  
Gail Rowlinson-Busza ◽  
Julie Cook ◽  
Agamemnon A. Epenetos

Nanoscale ◽  
2020 ◽  
Vol 12 (3) ◽  
pp. 2002-2010 ◽  
Author(s):  
Kang-Kang Yu ◽  
Kun Li ◽  
Chun-Yan Lu ◽  
Yong-Mei Xie ◽  
Yan-Hong Liu ◽  
...  

A number of multimodal agents have been developed for tumour imaging and diagnosis, but most of them cannot be used to study the detailed physiological or pathological changes in living cells at the same time.


Sign in / Sign up

Export Citation Format

Share Document